ResMed|'s free cash flow was $1.65 billion for fiscal year 2026 (the twelve months to 30 Jun 2026), down 0.7% from fiscal 2025.
In the first quarter of fiscal 2027 (the three months to 30 Sep 2026) it was $374 million, down 9.8% from a year earlier.
Over the four quarters to 30 Sep 2026, free cash flow was $1.61 billion.
From ResMed|'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 30 Oct 2026.
Fiscal 2026
$1.65B
−0.7%
Q1 FY2027
$374M
−9.8% on a year
Growth over 9 years
+18.7%
a year, FY 2017–FY 2026
Free cash flow by fiscal year
Change on the year before, under each year. From FY 2017 to FY 2026, ResMed|'s free cash flow went from $352 million to $1.65 billion, a compound annual change of +18.7%; the highest was $1.66 billion in FY 2025.
ResMed| free cash flow, fiscal years
Period
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
FY 2026
Free cash flow
$352M
$442M
$390M
$707M
$634M
$216M
$574M
$1.30B
$1.66B
$1.65B
Period end
30 Jun 2017
30 Jun 2018
30 Jun 2019
30 Jun 2020
30 Jun 2021
30 Jun 2022
30 Jun 2023
30 Jun 2024
30 Jun 2025
30 Jun 2026
Free cash flow by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
ResMed| free cash flow, fiscal quarters
Period
Q2 FY2025
Q3 FY2025
Q4 FY2025
Q1 FY2026
Q2 FY2026
Q3 FY2026
Q4 FY2026
Q1 FY2027
Free cash flow
$288M
$558M
$508M
$414M
$311M
$520M
$404M
$374M
Period end
31 Dec 2024
31 Mar 2025
30 Jun 2025
30 Sep 2025
31 Dec 2025
31 Mar 2026
30 Jun 2026
30 Sep 2026
How free cash flow is measured
Free cash flow is the cash generated by operations less capital expenditure: the cash a company has left to repay debt, pay dividends, buy back shares or invest. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
ResMed|'s other figures
Free cash flow of comparable companies
Everything on RMD, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.